Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
51,378,205
-
Share change
-
-1,919,202
-
Total reported value
-
$7,336,806,884
-
Put/Call ratio
-
141%
-
Price per share
-
$142.95
-
Number of holders
-
415
-
Value change
-
-$212,277,925
-
Number of buys
-
244
-
Number of sells
-
173
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q1 2019
As of 31 Mar 2019,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
415 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,378,205 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., FMR LLC, JPMORGAN CHASE & CO, RENAISSANCE TECHNOLOGIES LLC, TIAA CREF INVESTMENT MANAGEMENT LLC, STATE STREET CORP, Boston Partners, Bank of New York Mellon Corp, and PUTNAM INVESTMENTS LLC.
This page lists
416
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.